companyHealthcareSwitzerland

Roche

A Swiss multinational healthcare company specializing in pharmaceuticals and diagnostics.

Roche Annual Report 2024

F. Hoffmann-La Roche AG, known as Roche, is a global healthcare company headquartered in Basel, Switzerland. Founded in 1896, the company operates through two core divisions: Pharmaceuticals and Diagnostics, employing more than 100,000 people worldwide.

In 2024, Roche reported total revenue of CHF 60.5 billion, with a 7% sales growth at constant exchange rates. The company focuses on creating innovative medicines and diagnostic tests, with its primary therapeutic areas being Oncology, Neuroscience, and Immunology.

Roche integrates pharmaceutical and diagnostic expertise to enable earlier disease detection and more personalized treatments. Its long-term strategy aims to address disease areas expected to represent nearly 50% of the global disease burden over the next decade.

Ideas that could help Roche

Mutation-Risk Predictive Oncology Tool
A clinical decision support tool that predicts the window of time when a tumor is most likely to develop drug resistance based on its mutation rate.
Why it helps: They develop targeted cancer therapies and could use this model to optimize the timing of drug administration in clinical trials to avoid resistance.